title: Re: Pediatric ceftriaxone nephrolithiasis.
authors.forename: Zekai
authors.initials: Z
authors.lastname: Avci
authors.forename: Ahmet
authors.initials: A
authors.lastname: Karadag
authors.forename: Ender
authors.initials: E
authors.lastname: Odemis
authors.forename: Ferhat
authors.initials: F
authors.lastname: Catal
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002443:Ceftriaxone / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced*; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone